In a piece for Bloomberg, reporter Caroline Chen details a new Google-Biogen partnership:
“Google Inc., expanding its foray into medical research, will join multiple sclerosis drugmaker Biogen Idec Inc. to study environmental and biological contributors to the debilitating disease’s progression.
The collaboration is the second major pharmaceutical partnership for the life science division of Google X labs, which has hatched Google Glass and self-driving cars. Google X sees itself as providing the technical and innovative fire power for a “moonshot” in the health-care field, said Andrew Conrad, head of the division.
“Our central thesis is to change health care from being reactive to proactive,” Conrad said in a telephone interview. “We’re trying to understand disease at its onset and see if we can intervene early.”